INDIAN PHARMACOPOEIA COMMISSION
Ministry of Health & Family Welfare, Government of India
Inauguration of 6th Asia-Pacific Pharmacovigilance Training Course
The Indian Pharmacopoeia Commission (IPC), National Coordination Centre for Pharmacovigilance Programme of India (NCC-PvPI), Ministry of Health & Family Welfare, Government of India has been organizing 6th“Asia Pacific Pharmacovigilance (PV) Training Course” from 24th February to 6th March, 2020 at Hotel Radisson Blu, Kaushambi, Ghaziabad. The course is tailored to meet regional needs and address challenges unique to PV. The purpose of the course is to further develop effective and sustainable PV Practices for member countries of the WHO Programme for International Drug Monitoring (WHO-PIDM) and creating a unique opportunity for learning and collaboration for individuals involved in this highly specialized field.
The 14 participants, from 6 countries-Nigeria, India, Zimbabwe, Philippines, Yemen and Bangladesh are participating in this training course. The training was inaugurated on 24th February, 2020. The chief guest of the inaugural session, Dr. V. G. Somani, Drugs Controller General of India (DCGI) appreciated the efforts made by IPC for continuously working towards ensuring the quality as well as the safety of medical products used in Indian population. He also applauded the team efforts of IPC for organizing Asia-Pacific PV training course to upgrade the PV systems in Low and Middle Income Countries (LMICs) in the region. Dr. Jai Prakash, Secretary-cum-Scientific Director (I/c), IPC, Ministry of Health & Family Welfare, Government of India, welcomed participants and highlighted about the historical background, objectives and expectations of international trainees from this event as well as IPC’s commitment to extend PV training & technical Support to WHO member countries besides ensuring sustainable PV system development in India. Dr. G.N. Singh, Former DCG(I)/ Secretary-cum-Scientific Director, IPC, Ms. Therese Lundin, PV Officer, Uppsala Monitoring Centre (UMC) also shared the dais during the inaugural ceremony and appreciated the efforts of PvPI for strengthening the Pharmacovigilance in public health and regulatory services in India and Asia Pacific Region. The Inaugural session ended with a vote of thanks by Dr. V. Kalaiselvan, Principal Scientific Officer, IPC.
The International PV experts from WHO, WHO Collaborating Centres, MHRA, UMC, Drug Regulatory Authorities, Academic Institutions, IPC and the pharmaceutical industries will lead the technical sessions. This 10-days training programme will ensure capacity building in the area of Pharmacovigilance within Asia-Pacific region and beyond. The participants will be acquainted on basic as well as advanced knowledge to promote safe use of medicines. Overall, this training programme will be useful in strengthening PV activity at their respective organizations/countries in order to protect the safety and well-being of the patients.
The Glimpse of the Inauguration Programme :